HomeAGN • CNSX
add
Algernon Pharmaceuticals Inc
Previous close
$0.12
Day range
$0.12 - $0.14
Year range
$0.050 - $0.30
Market cap
2.49M CAD
Avg Volume
30.49K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
In the news
Financials
Income Statement
Revenue
Net income
(CAD) | Nov 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 503.10K | -72.32% |
Net income | -521.55K | 72.26% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -495.68K | 72.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Nov 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 74.17K | -89.25% |
Total assets | 3.95M | -40.79% |
Total liabilities | 2.94M | 31.34% |
Total equity | 1.01M | — |
Shares outstanding | 20.02M | — |
Price to book | 2.00 | — |
Return on assets | -30.88% | — |
Return on capital | -101.16% | — |
Cash Flow
Net change in cash
(CAD) | Nov 2023info | Y/Y change |
---|---|---|
Net income | -521.55K | 72.26% |
Cash from operations | -52.24K | 93.53% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -50.92K | 92.92% |
Free cash flow | 148.07K | 485.68% |
About
Founded
2015
Headquarters
Website